نتایج جستجو برای: vrsa

تعداد نتایج: 217  

Journal: :Antimicrobial agents and chemotherapy 2009
Bruno Périchon Patrice Courvalin

Since 2002, nine methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) strains that are also resistant to vancomycin (VRSA) have been reported in the United States, including seven clinical isolates from Michigan. The strains harbor a plasmid-borne Tn1546 element following conjugation from a glycopeptide-resistant Enterococcus strain. In the second step, Tn1546 transposed to a residen...

Journal: :Antimicrobial agents and chemotherapy 2003
Raymond Cha William J Brown Michael J Rybak

In search of treatment alternatives against vancomycin-resistant S. aureus (VRSA), an in vitro pharmacodynamic model with simulated endocardial vegetations incorporating protein and a high inoculum was used to simulate daptomycin, linezolid, quinupristin-dalfopristin, and vancomycin against the Michigan VRSA strain. Daptomycin and quinupristin-dalfopristin exhibited the greatest bacterial reduc...

2011
Subhankari Prasad Chakraborty Santanu Kar Mahapatra Sumanta Kumar Sahu Sabyasachi Das Satyajit Tripathy Sandeep Dash Panchanan Pramanik Somenath Roy

Staphylococcus aureus is the most frequently isolated pathogen causing bloodstream infections, skin and soft tissue infections and pneumonia. Lymphocyte is an important immune cell. The aim of the present paper was to test the ameliorative role of nanoconjugated vancomycin against Vancomycin-sensitive Staphylococcus aureus (VSSA) and vancomycin-resistant Staphylococcus aureus (VRSA) infection-i...

Journal: :Antimicrobial agents and chemotherapy 2009
Marie-Laure Foucault Patrice Courvalin Catherine Grillot-Courvalin

We have quantified the biological cost of VanA-type glycopeptide resistance due to the acquisition of the resistance operon by methicillin-resistant Staphylococcus aureus (MRSA) from Enterococcus sp. Exponential growths of recipient strain HIP11713, its transconjugant VRSA-1, VRSA-5, and VRSA-6 were compared in the absence or, except for HIP11713, in the presence of vancomycin. Induction of res...

2017
Marjan Shekarabi Bahareh Hajikhani Alireza Salimi Chirani Maryam Fazeli Mehdi Goudarzi

INTRODUCTION Emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant S. aureus (VRSA) strains has led to great concern in global public health in both developing and developed countries. This study investigated distribution and molecular characterization of VRSA strains in Tehran's hospitals using a combination of molecular typing methods. MATERIALS AND METH...

2011
SUBHANKARI PRASAD CHAKRABORTY SABYASACHI DAS PANCHANAN PRAMANIK SOMENATH ROY

Staphylococcus aureus is a most common pathogen in hospital and community acquired disease that causes a wide range of infection such as skin and soft tissue infection to life threatening disease like respiratory tract infection, musculoskeletal infection, endocarditis and urinary tract infection. The aim of the present study was to evaluate the possible protective effects of nanoconjugated van...

2012
Anahita Dezfulian Mohammad Mehdi Aslani Mahvash Oskoui Parisa Farrokh Masumeh Azimirad Hossein Dabiri Mohammad Taghi Salehian Mohammad Reza Zali

OBJECTIVES Staphylococcus aureus is a common cause of human infection, and emergence of vancomycin-resistance S. aureus is a great concern for treatment of methicillin-resistant S. aureus,(MRSA) in recent years (MRSA). Here, we report the isolation of high-level VRSA. MATERIALS AND METHODS S. aureus was isolated from foot ulcer of a diabetic woman in Tehran, Iran. Antibiotic susceptibility wa...

2012
Subhankari Prasad Chakraborty Panchanan Pramanik Somenath Roy

Staphylococcus aureus infection causes oxidative stress in neutrophils. The immune cells use reactive oxygen species (ROS) for carrying out their normal functions while an excess amount of ROS can attack cellular components that lead to cell damage. The present study was aimed to test the protective role of nanoconjugated vancomycin against vancomycin-sensitive Staphylococcus aureus (VSSA) and ...

2008
Hussein Azzam Bataineh

Background: Vancomycin has been widely used in the treatment of infections caused by Methicillin-Resistant Staphylococcus Aureus (MRSA). The emergence of VancomycinIntermediate and -Resistant Staphylococcus Aureus (VISA and VRSA, respectively) in various parts of the world has been of great concern in clinical settings. Objective: This study was performed to evaluate the possible presence of VI...

Journal: :Antimicrobial agents and chemotherapy 2010
Wenming Zhu Patrick R Murray W Charles Huskins John A Jernigan Lawrence C McDonald Nancye C Clark Karen F Anderson Linda K McDougal Jeff C Hageman Melissa Olsen-Rasmussen Mike Frace George J Alangaden Carol Chenoweth Marcus J Zervos Barbara Robinson-Dunn Paul C Schreckenberger L Barth Reller James T Rudrik Jean B Patel

Of the 9 vancomycin-resistant Staphylococcus aureus (VRSA) cases reported to date in the literature, 7 occurred in Michigan. In 5 of the 7 Michigan VRSA cases, an Inc18-like vanA plasmid was identified in the VRSA isolate and/or an associated vancomycin-resistant Enterococcus (VRE) isolate from the same patient. This plasmid may play a critical role in the emergence of VRSA. We studied the geog...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید